These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28250029)

  • 1. Stability of mild cognitive impairment in newly diagnosed Parkinson's disease.
    Lawson RA; Yarnall AJ; Duncan GW; Breen DP; Khoo TK; Williams-Gray CH; Barker RA; Burn DJ;
    J Neurol Neurosurg Psychiatry; 2017 Aug; 88(8):648-652. PubMed ID: 28250029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the utility of the Movement Disorder Society Task Force Level 1 diagnostic criteria for mild cognitive impairment in Parkinson's disease.
    Szeto JY; Mowszowski L; Gilat M; Walton CC; Naismith SL; Lewis SJ
    Parkinsonism Relat Disord; 2015 Jan; 21(1):31-5. PubMed ID: 25465744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.
    Phannarus H; Muangpaisan W; Siritipakorn P; Chotinaiwattarakul W
    Psychogeriatrics; 2020 Jan; 20(1):20-27. PubMed ID: 30912230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assessment of Movement Disorder Society Task Force diagnostic criteria for mild cognitive impairment in Parkinson's disease.
    Uysal-Cantürk P; Hanağası HA; Bilgiç B; Gürvit H; Emre M
    Eur J Neurol; 2018 Jan; 25(1):148-153. PubMed ID: 28941002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
    Hobson P; Meara J
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion to MCI and dementia in Parkinson's disease: a systematic review and meta-analysis.
    Saredakis D; Collins-Praino LE; Gutteridge DS; Stephan BCM; Keage HAD
    Parkinsonism Relat Disord; 2019 Aug; 65():20-31. PubMed ID: 31109727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease mild cognitive impairment classifications and neurobehavioral symptoms.
    McDermott KL; Fisher N; Bradford S; Camicioli R
    Int Psychogeriatr; 2018 Feb; 30(2):253-260. PubMed ID: 29094664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.
    Goldman JG; Holden S; Bernard B; Ouyang B; Goetz CG; Stebbins GT
    Mov Disord; 2013 Dec; 28(14):1972-9. PubMed ID: 24123267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global assessment, cognitive profile, and characteristics of mild cognitive impairment in Parkinson's disease.
    Yang J; Pourzinal D; Byrne GJ; McMahon KL; Copland DA; O'Sullivan JD; Mitchell L; Dissanayaka NN
    Int J Geriatr Psychiatry; 2023 Jun; 38(6):e5955. PubMed ID: 37318156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which Neuropsychological Tests? Predicting Cognitive Decline and Dementia in Parkinson's Disease in the ICICLE-PD Cohort.
    Lawson RA; Williams-Gray CH; Camacho M; Duncan GW; Khoo TK; Breen DP; Barker RA; Rochester L; Burn DJ; Yarnall AJ;
    J Parkinsons Dis; 2021; 11(3):1297-1308. PubMed ID: 34024781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild Cognitive Impairment in Early Parkinson's Disease Using the Movement Disorder Society Task Force Criteria: Cross-Sectional Study in Hoehn and Yahr Stage 1.
    Stefanova E; Žiropadja L; Stojković T; Stanković I; Tomić A; Ječmenica-Lukić M; Petrović I; Kostić V
    Dement Geriatr Cogn Disord; 2015; 40(3-4):199-209. PubMed ID: 26226988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond PD-MCI: objectively defined subtle cognitive decline predicts future cognitive and functional changes.
    Jones JD; Uribe C; Bunch J; Thomas KR
    J Neurol; 2021 Jan; 268(1):337-345. PubMed ID: 32804281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reverters from PD-MCI to cognitively intact are at risk for future cognitive impairment: Analysis of the PPMI cohort.
    Jones JD; Kuhn TP; Szymkowicz SM
    Parkinsonism Relat Disord; 2018 Feb; 47():3-7. PubMed ID: 29233608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Cognitive-Driven Performance-Based Activities of Daily Living Dysfunction in Parkinson's Disease.
    Sulzer P; Bäumer A; Hoang HG; Becker S; Lönneker HD; Graessel E; Liepelt-Scarfone I
    J Int Neuropsychol Soc; 2020 Apr; 26(4):430-440. PubMed ID: 31822319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia.
    Janvin CC; Larsen JP; Aarsland D; Hugdahl K
    Mov Disord; 2006 Sep; 21(9):1343-9. PubMed ID: 16721732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of cognitive impairment in an early stage Parkinson's disease cohort.
    Hu MT; Szewczyk-Królikowski K; Tomlinson P; Nithi K; Rolinski M; Murray C; Talbot K; Ebmeier KP; Mackay CE; Ben-Shlomo Y
    Mov Disord; 2014 Mar; 29(3):351-9. PubMed ID: 24395708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.
    Pedersen KF; Larsen JP; Tysnes OB; Alves G
    JAMA Neurol; 2013 May; 70(5):580-6. PubMed ID: 23529397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study.
    Pedersen KF; Larsen JP; Tysnes OB; Alves G
    Neurology; 2017 Feb; 88(8):767-774. PubMed ID: 28108638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.